EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic value of aMMP‐8 and azurocidin in peri‐implant sulcular fluid as biomarkers of peri‐implant health or disease

Vithleem Xanthopoulou iD, Ismo T Räisänen iD, Timo Sorsa, Dimitrios Tortopidis iD, Dimitra Sakellari

Clinical and Experimental Dental Research · 2024

DOI: 10.1002/cre2.883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, 2024. Verfasst von Vithleem Xanthopoulou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 8, Biomarkers, Peri-Implantitis, Dental Implants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsinki and Uusimaa Hospital District (HUS), Finnish Dental Society Apollonia, Finland, karolisnka institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to investigate the effectiveness of testing for active matrix metalloproteinase‐8 (aMMP‐8) by a quantitative point‐of‐care (PoC), chairside lateral flow immunotest and azurocidin, in the peri‐implant sulcular fluid (PISF), as biomarkers for the presence or absence of peri‐implant diseases.

Background

Current research indicates that proinflammatory cytokines and extracellular matrix‐degrading enzymes may be of value to diagnose and predict peri‐implant disease initiation and progression, but more data are needed.

Methods

Eighty patients with implants were recruited. PISF samples were collected and quantitatively analyzed for aMMP‐8 (chairside) and azurocidin with ELISA. Radiographic assessments and clinical indices (probing depth, probing attachment level, bleeding on probing, and plaque) were recorded after sampling. Kruskal‐Wallis test and pairwise post hoc Dunn‐Bonferroni test were used to relate aMMP‐8 levels and azurocidin levels to clinical parameters. The diagnostic ability of aMMP‐8 (ng/mL) and azurocidin was analyzed by receiver operator curve analysis. Area under the curve (AUC) was calculated and the Spearman's rho, and the coefficient of determination (R 2 ) were used to calculate the correlations between aMMP‐8, azurocidin, and periodontal parameters.

Results

Statistically significant differences were observed for aMMP‐8 levels but not for azurocidin between healthy implants, implants with mucositis, and those with peri‐implantitis (13.65 ± 7.18, 32.33 ± 21.20, and 73.07 ± 43.93 ng/mL, respectively), (Kruskall–Wallis test p < .05). The aMMP‐8 test with a threshold of 20 ng/mL has a sensitivity of 71.7% and a specificity of 77.8% to identify peri‐implantitis and healthy implants, respectively. AUC was found to be 0.814, and the accuracy of the method reaches 73.8%. Above a cutoff value of 33.7 ng/mL of aMMP‐8, the accuracy of the test to detect peri‐implantitis reaches 77.5% in relation to 62.5% of BoP from the same site.

Conclusion

Taken collectively, present data indicate that the aMMP‐8 PoC lateral flow immunotest can be a beneficial, adjunctive diagnostic quantitative tool for real‐time screening for peri‐implant diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 8BiomarkersPeri-ImplantitisDental ImplantsGingival Crevicular FluidHumansMaleFemaleMiddle AgedAgedAdultEnzyme-Linked Immunosorbent AssayPeriodontal IndexROC CurveBlood ProteinsAntimicrobial Cationic Peptides

Stichwörter der Autor:innen

aMMP‐8azurocidinperi‐implant diseaseperi‐implant health

Substanzen

Matrix Metalloproteinase 8BiomarkersAZU1 protein, humanDental ImplantsMMP8 protein, humanBlood ProteinsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Preventive Dentistry, Periodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Prosthodontics, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Vithleem Xanthopoulou, Ismo T Räisänen, Dimitrios Tortopidis

Förderung

  • Helsinki and Uusimaa Hospital District (HUS)
  • Finnish Dental Society Apollonia, Finland
  • karolisnka institute

Zitieren

APA

Xanthopoulou, V., Räisänen, I. T., Sorsa, T., Tortopidis, D., & Sakellari, D. (2024). Diagnostic value of aMMP‐8 and azurocidin in peri‐implant sulcular fluid as biomarkers of peri‐implant health or disease. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.883

Vancouver

Xanthopoulou V, Räisänen IT, Sorsa T, Tortopidis D, Sakellari D. Diagnostic value of aMMP‐8 and azurocidin in peri‐implant sulcular fluid as biomarkers of peri‐implant health or disease. Clinical and Experimental Dental Research. 2024. doi:10.1002/cre2.883

BibTeX
@article{Xanthopoulou2024,
  author = {Xanthopoulou, Vithleem and Räisänen, Ismo T and Sorsa, Timo and Tortopidis, Dimitrios and Sakellari, Dimitra},
  title = {Diagnostic value of aMMP‐8 and azurocidin in peri‐implant sulcular fluid as biomarkers of peri‐implant health or disease},
  journal = {Clinical and Experimental Dental Research},
  year = {2024},
  doi = {10.1002/cre2.883}
}
Kostenlos starten →